EBRO 2017

Chemoradiotherapy compensates for poor surgery? Gastric cancer adjuvant chemoradiation

EBRO 2017

A meta-analysis (n=2811)

No benifit on Overall Survivial in D2 subgroup

D0

D1

D2

Ohri et al. IJROBP 2013

Made with FlippingBook Learn more on our blog